Stefan Constantin Ionel sold $426K of AMPX

Stefan Constantin Ionel (Chief Technology Officer) sold 28,812 shares of Amprius Technologies, Inc. (AMPX) at $14.79 ($0.43M total) on 2026-05-21.

Original reporting
SEC EDGAR · Stefan Constantin Ionel
Published May 26, 2026, 11:10 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI May 26, 2026, 11:11 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$AMPX
Neutral
medium confidence
Mentioned
$AMPX
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AMPXNeutralMed
01

Why it matters

Because the filing only reports an open-market sale by the CTO and does not include performance, guidance, or deal information, the market signal is weaker than event-driven news.

02

Market read

Traders may treat the disclosure as a modest sentiment input, but it is unlikely to drive a major repricing absent additional catalysts.

03

What to watch

Check whether other insiders/funds also sold around the same dates and whether AMPX price action already incorporated insider-selling expectations.

Relevance 7/10Timing: Immediate (new SEC Form 4 filed 2026-05-26; trading impact, if any, likely same/next session).

Background

The article is a SEC Form 4 insider transaction disclosure for Amprius Technologies, Inc. (AMPX).

Company-level read

Ticker impact

$AMPXNeutralMedium confidence
Context

AMPX CTO Stefan Constantin Ionel sold 28,812 shares in an open-market transaction disclosed via SEC Form 4.

Expected impact

Likely limited/short-lived impact; watch for follow-through selling volume rather than a directional repricing.

Evidence & confidence

The disclosure is an officer sale (no 10b5-1 plan stated) but provides no operational or financial update, so market reaction is typically modest unless part of a broader pattern.

Market effects

Minimal; this is company-specific insider activity without sector-wide read-across details.

None indicated; filing is US SEC EDGAR with no geographic catalyst.

None indicated; no international transaction or guidance change mentioned.

Counterpoint

The sale could be routine liquidity management (even without a stated 10b5-1 plan), so it may not signal reduced confidence.

Key entities

  • Amprius Technologies, Inc.

    Subject of the SEC Form 4 insider sale by its CTO.

  • Stefan Constantin Ionel

    Chief Technology Officer who sold 28,812 shares at $14.7884/share.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AMPXMedAI 8/10

Amprius (AMPX) Q3 2026 Earnings Call Transcript

Amprius reported Q3 2026 revenue of $39.1M, up 83% YoY, raising its full-year target to $145M. The company introduced SiCore 500 cells for aviation and secured a $75M U.S. defense contract. Amprius expanded into maritime vehicles and partnered with U.S. manufacturers for NDAA-compliant production.

$AMPXMedAI 8/10

Amprius Technologies Q3 Earnings Call Highlights

Amprius reported a Q3 net loss of $3.5M, with adjusted EBITDA at -$1M. The company maintained its full-year gross margin forecast of 28% and expects Q4 sales of $43.3M. Amprius is expanding manufacturing to meet demand, with a $75M contract for a U.S. battery production line. It also introduced new products for aviation and deep-sea applications, ending Q3 with $60.7M in cash.

$AMPXHigh

Amprius Technologies falls 7% on third quarter earnings miss

Amprius Technologies (NYSE:AMPX) reported Q3 earnings missing estimates with a loss of $0.02 per share, though revenue of $39.1M beat expectations. Shares fell 7.7% after-hours. The company raised its full-year 2026 revenue outlook to $145M, above analyst forecasts. Gross profit rose 217% YoY to $10.5M, with gross margin improving to 27%. Amprius secured a $75M U.S. Department of War contract and introduced a new battery cell.

$AMPXMed

Amprius Technologies Reports Third Quarter 2026 Financial Results and Recent

Amprius Technologies, Inc. (AMPX) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Amprius Technologies Reports Third Quarter 2026 Financial Results and Recent Business Highlights • Q3 2026 revenue increased 83% year-over-year to $39.1 million • Net loss of $3.5 million, a 10% year-over-year improvement • Increasing 2026 revenue outlook to $145 mil

$AMPXHigh

AMPX Stock Jumps As Defense Deals Supercharge Growth Story

Amprius Technologies Inc. (NYSE: AMPX) shares rose 8.38% on October 21, 2026, driven by U.S. Department of War funding and a partnership with Caminus for battery production. The company secured $75M in funding for a high-energy-density cell plant, with revenue growth but negative margins. Canaccord Genuity initiated coverage with a Buy rating and $14 price target.